Since our study provided the first evidence of LBN 306–313 and ACCN4 613–624 detection in human serum, further analysis of physiological functions and measurement in other diseases should be required for the proper use in clinical lung cancer diagnosis. This evidence concerns the gene ASIC4 and lung carcinoma.